Related Experiment Video
Updated: Jun 22, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis
Ren-Nan Feng1, Ying Li, Chang-Hao Sun
1Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150086, China.
Diabetes Research and Clinical Practice
|May 30, 2009
Summary
The tumor necrosis factor (TNF) 308 G/A polymorphism is linked to an increased risk of type 1 diabetes (T1DM). This meta-analysis confirms that the TNF 308 A allele significantly elevates T1DM risk.
Area of Science:
- Genetics
- Immunology
- Endocrinology
Background:
- Type 1 diabetes (T1DM) is an autoimmune disease with complex genetic components.
- The tumor necrosis factor (TNF) gene is a key cytokine involved in immune regulation and inflammation.
- The TNF 308 G/A polymorphism has been investigated for its potential role in T1DM susceptibility.
Purpose of the Study:
- To conduct a meta-analysis evaluating the association between the TNF 308 G/A polymorphism and the risk of developing T1DM.
- To synthesize existing evidence regarding the impact of this specific genetic variation on T1DM.
- To provide a comprehensive overview of the current research findings.
Main Methods:
- A systematic literature search was performed to identify relevant studies.
- Eleven independent reports investigating the TNF 308 G/A polymorphism and T1DM risk were included.
- Statistical methods were employed to pool the data and assess the overall association.
Main Results:
- The meta-analysis confirmed a significant association between the TNF 308 G/A polymorphism and T1DM risk.
- A higher frequency of the TNF 308 A allele was found to confer a significant risk for T1DM.
- The results indicate a genetic predisposition linked to this specific TNF variant.
Conclusions:
- The TNF 308 A allele is a significant risk factor for type 1 diabetes.
- This genetic variant may play a crucial role in the pathogenesis of T1DM.
- Further research into the functional implications of the TNF 308 G/A polymorphism is warranted.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...